171 related articles for article (PubMed ID: 24054033)
1. Downregulation of GLTSCR2 expression is correlated with breast cancer progression.
Moon A; Lim SJ; Jo YH; Lee S; Kim JY; Lee J; Park JH
Pathol Res Pract; 2013 Nov; 209(11):700-4. PubMed ID: 24054033
[TBL] [Abstract][Full Text] [Related]
2. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.
Shao F; Guo T; Chua PJ; Tang L; Thike AA; Tan PH; Bay BH; Baeg GH
Histopathology; 2015 Nov; 67(5):709-18. PubMed ID: 25817822
[TBL] [Abstract][Full Text] [Related]
6. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
7. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
8. Suppression of GLTSCR2 expression in renal cell carcinomas.
Cho YE; Lee HL; Lim SJ; Kim YW; Choe BK; Lee S; Park JH
Pathol Res Pract; 2016 Feb; 212(2):120-4. PubMed ID: 26724143
[TBL] [Abstract][Full Text] [Related]
9. [Expressions of Fas, CTLA-4 and RhoBTB2 genes in breast carcinoma and their relationship with clinicopathological factors].
Bi Y; Wei L; Mao HT; Zhang L; Zuo WS
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):749-53. PubMed ID: 19173804
[TBL] [Abstract][Full Text] [Related]
10. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.
Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O
Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119
[TBL] [Abstract][Full Text] [Related]
11. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.
Pula B; Jethon A; Piotrowska A; Gomulkiewicz A; Owczarek T; Calik J; Wojnar A; Witkiewicz W; Rys J; Ugorski M; Dziegiel P; Podhorska-Okolow M
Histopathology; 2011 Dec; 59(6):1249-60. PubMed ID: 22175904
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer.
Nie F; Yu XL; Wang XG; Tang YF; Wang LL; Ma L
Int J Oncol; 2010 Nov; 37(5):1261-9. PubMed ID: 20878073
[TBL] [Abstract][Full Text] [Related]
14. Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.
Hsing CH; Cheng HC; Hsu YH; Chan CH; Yeh CH; Li CF; Chang MS
Clin Cancer Res; 2012 Feb; 18(3):713-25. PubMed ID: 22186257
[TBL] [Abstract][Full Text] [Related]
15. Suppression of putative tumour suppressor gene GLTSCR2 expression in human glioblastomas.
Kim YJ; Cho YE; Kim YW; Kim JY; Lee S; Park JH
J Pathol; 2008 Oct; 216(2):218-24. PubMed ID: 18729076
[TBL] [Abstract][Full Text] [Related]
16. PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast.
Qian L; Gao X; Huang H; Lu S; Cai Y; Hua Y; Liu Y; Zhang J
Oncotarget; 2017 Mar; 8(13):21444-21453. PubMed ID: 28423522
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of CADM4 expression in invasive ductal carcinoma of the breast.
Jang SM; Sim J; Han H; Ahn HI; Kim H; Yi K; Jun YJ; Rehman A; Chung MS; Jang K; Paik SS
J Clin Pathol; 2013 Aug; 66(8):681-6. PubMed ID: 23559354
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
20. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]